Related Experiment Videos

Preischemic perfusion of hypertrophied myocardium with perfluorocarbons

M S Soberman1, J D Sink, G C Forest

  • 1Joseph B. Whitehead Department of Surgery, Emory University School of Medicine, Atlanta, Georgia 30322.

Insights

Preischemic perfusion with oxygenated perfluorocarbon cardioplegia (FC-43) can restore normal ATP levels in hypertrophied rat hearts. This intervention significantly prolongs the time before ischemic contracture, enhancing cardiac tolerance to ischemia.

Area of Science:

  • Cardiology
  • Biochemistry
  • Physiology

Background:

  • Hypertrophied myocardium exhibits increased susceptibility to ischemic injury.
  • These hearts have lower pre-ischemic high-energy phosphate stores and shorter tolerance to ischemia.
  • Ischemic contracture develops more rapidly in hypertrophied hearts compared to normal hearts.

Purpose of the Study:

  • To evaluate the efficacy of preischemic arrested perfusion with oxygenated, glucose-containing perfluorocarbon cardioplegia (FC-43).
  • To determine if FC-43 perfusion can restore normal myocardial ATP stores in hypertrophied rat hearts.
  • To assess the impact of FC-43 perfusion on prolonging the duration of global ischemia before contracture initiation.

Main Methods:

  • Utilized a modified Langendorff preparation for normal (NL) and hypertrophied (spontaneously hypertensive rats - SHR) rat hearts.
  • Subjected hearts to 2 or 15 minutes of preischemic, arrested perfusion with FC-43.
  • Measured adenosine triphosphate (ATP) levels via High-Performance Liquid Chromatography (HPLC) and recorded the time to ischemic contracture initiation.

Main Results:

  • Two minutes of FC-43 perfusion restored ATP levels in SHR hearts to those of normal controls (P = NS).
  • FC-43 perfusion significantly prolonged the time to initiation of ischemic contracture by 107% in the SHR group.
  • No significant difference in ATP levels was observed between normal controls and SHR hearts post-perfusion.

Conclusions:

  • Oxygenated perfluorocarbon cardioplegia (FC-43) effectively restores myocardial ATP stores in hypertrophied hearts.
  • FC-43 perfusion enhances tolerance to global ischemia by delaying ischemic contracture.
  • Perfluorocarbons represent a promising vehicle for interventions aimed at improving hypertrophied heart resistance to ischemia.

Related Concept Videos